V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016453 | 220006410 | 1.6 | 46.9 | Curative (C) | 2015-02-04 | 2015-03-15 | AML Interim Guidelines FLAG-Ida | Y | N | 220024357 | FLAG + IDARUBICIN |
| 220016454 | 220006412 | 1.68 | null | Curative (C) | 2017-07-01 | 2017-07-01 | AML Interim Guidelines FLAG-Ida | N | N | 220024371 | FLAG + IDARUBICIN |
| 220016455 | 220006414 | 1.85 | 76 | Curative (C) | 2015-02-06 | 2015-02-12 | FLAG + Idarubicin | 02 | N | 220024373 | FLAG + IDARUBICIN |
| 220016456 | 220006415 | null | 51.4 | Curative (C) | 2013-05-30 | 2014-02-04 | FLAG + Idarubicin | 02 | N | 220024378 | FLAG + IDARUBICIN |
| 220016458 | 220006419 | 1.8 | 139.8 | Curative (C) | 2014-06-29 | 2014-08-09 | AML17 TRIAL | Y | N | 220024404 | AML17 TRIAL |
| 220016459 | 220017365 | 1.71 | 71 | null | 2016-12-27 | 2017-02-07 | FLAG + Idarubicin | Y | N | 220024410 | FLAG + IDARUBICIN |
| 220016460 | 220006421 | 1.71 | 72.5 | Palliative (P) | 2013-10-15 | 2013-11-18 | FLAG + Idarubicin | Y | N | 220024410 | FLAG + IDARUBICIN |
| 220016461 | 220006425 | 1.61 | 99 | Curative (C) | 2018-06-24 | 2018-07-14 | FLAG + Idarubicin | 02 | N | 220024421 | FLAG + IDARUBICIN |
| 220016462 | 220006426 | 1.71 | 74.4 | Curative (C) | 2016-03-27 | 2016-05-02 | FLAG + Idarubicin | Y | N | 220024421 | FLAG + IDARUBICIN |
| 220016463 | 220006427 | null | 79.8 | Curative (C) | 2015-01-19 | 2015-05-08 | FLAG + Idarubicin | 02 | N | 220024423 | FLAG + IDARUBICIN |
| 220016464 | 220017370 | 1.59 | 62 | Curative (C) | 2017-06-03 | 2017-06-03 | FLAG + Idarubicin | N | N | 220024432 | FLAG + IDARUBICIN |
| 220016465 | 220006429 | null | 73.5 | Curative (C) | 2017-09-25 | 2017-12-08 | AML17 TRIAL | N | Y | 220024432 | AML17 TRIAL |
| 220016466 | 220006432 | 1.65 | 76.7 | Curative (C) | 2016-08-21 | 2016-08-25 | FLAG + Idarubicin | 01 | N | 220024446 | FLAG + IDARUBICIN |
| 220016467 | 220013493 | 1.74 | 78 | Curative (C) | null | 2017-07-27 | AML17 TRIAL | N | N | 220024448 | AML17 TRIAL |
| 220016468 | 220013493 | 1.85 | null | Curative (C) | 2015-11-12 | 2015-11-19 | AML17 TRIAL | N | null | 220024448 | AML17 TRIAL |
| 220016469 | 220006434 | 1.63 | 70 | Neo-adjuvant (N) | 2016-01-15 | 2016-01-19 | FLAG + Idarubicin | N | N | 220024454 | FLAG + IDARUBICIN |
| 220016470 | 220013494 | null | 56.5 | Curative (C) | 2018-01-29 | 2018-03-05 | FLAG + Idarubicin | Y | null | 220024461 | FLAG + IDARUBICIN |
| 220016471 | 220006435 | 1.85 | 82 | Curative (C) | 2016-11-25 | 2016-11-27 | FLAG + Idarubicin | N | N | 220024464 | FLAG + IDARUBICIN |
| 220016473 | 220006439 | 1.81 | 78.9 | Curative (C) | 2015-04-08 | 2015-04-08 | AML17 TRIAL | 99 | N | 220024479 | AML17 TRIAL |
| 220016474 | 220006441 | 1.64 | 76.3 | Disease modification (D) | 2014-04-02 | 2014-04-04 | AML17 TRIAL | 02 | N | 220024482 | AML17 TRIAL |
| 220016475 | 220006443 | 1.7 | 59.9 | Palliative (P) | 1998-01-20 | 2014-11-21 | FLAG + Idarubicin | Y | N | 220024482 | FLAG + IDARUBICIN |
| 220016476 | 220006444 | 1.79 | 73.8 | Curative (C) | 2014-10-25 | 2014-10-26 | AML17 TRIAL | N | N | 220024501 | AML17 TRIAL |
| 220016477 | 220006447 | 1.82 | 86.8 | null | 2014-07-06 | 2014-09-02 | FLAG + Idarubicin | 2 | N | 220024509 | FLAG + IDARUBICIN |
| 220016479 | 220006451 | 1.86 | 73.8 | Curative (C) | 2014-10-27 | 2015-01-05 | AML17 TRIAL | N | N | 220024525 | AML17 TRIAL |
| 220016480 | 220006453 | 1.77 | 91 | null | 2015-08-17 | 2015-11-04 | AML17 TRIAL | Y | N | 220024527 | AML17 TRIAL |
| 220016481 | 220006455 | 1.52 | null | Curative (C) | 2017-03-04 | 2017-05-20 | AML17 TRIAL | Y | N | 220024528 | AML17 TRIAL |
| 220016482 | 220006457 | 1.63 | 86.2 | Curative (C) | 2018-04-25 | 2018-04-27 | FLAG + Idarubicin | 99 | N | 220024534 | FLAG + IDARUBICIN |
| 220016483 | 220006459 | 1.6 | 49.6 | Curative (C) | 2014-07-10 | 2014-07-10 | AML17 TRIAL | N | N | 220024538 | AML17 TRIAL |
| 220016484 | 220013517 | null | 103.4 | Curative (C) | 2016-10-31 | 2017-01-05 | FLAG + Idarubicin | Y | null | 220024547 | FLAG + IDARUBICIN |
| 220016485 | 220006463 | 1.93 | 55.8 | Curative (C) | 2013-10-20 | 2013-11-23 | AML17 TRIAL | Y | N | 220024548 | AML17 TRIAL |
| 220016486 | 220017380 | 1.5 | null | Adjuvant (A) | 2015-01-22 | 2015-01-22 | AML17 TRIAL | 2 | N | 220024554 | AML17 TRIAL |
| 220016487 | 220021843 | 1.59 | 80 | Curative (C) | 2017-08-30 | 2017-09-03 | FLAG + Idarubicin | 1 | N | 220024560 | FLAG + IDARUBICIN |
| 220016488 | 220006464 | 1.65 | 122 | Curative (C) | 2013-12-09 | 2013-12-11 | FLAG + Idarubicin | N | N | 220024572 | FLAG + IDARUBICIN |
| 220016490 | 220006467 | 1.73 | 104.2 | Curative (C) | 2018-01-30 | 2018-02-03 | AML Interim Guidelines FLAG-Ida | 2 | N | 220024598 | FLAG + IDARUBICIN |
| 220016492 | 220006471 | 1.75 | 65 | Curative (C) | 2014-12-06 | 2017-02-12 | FLAG + Idarubicin | Y | N | 220024615 | FLAG + IDARUBICIN |
| 220016493 | 220017383 | 1.8 | 66.7 | Disease modification (D) | 2015-10-18 | 2015-10-23 | FLAG + Idarubicin | 02 | N | 220024633 | FLAG + IDARUBICIN |
| 220016494 | 220017384 | null | 63.9 | Radical (R) | 2017-06-25 | 2017-06-25 | FLAG + Idarubicin | 01 | N | 220024639 | FLAG + IDARUBICIN |
| 220016495 | 220006479 | 1.6 | 89 | null | 2018-05-15 | 2018-07-01 | FLAG + Idarubicin | Y | null | 220024651 | FLAG + IDARUBICIN |
| 220016496 | 220017385 | 1.64 | 56.3 | Disease modification (D) | 2014-08-03 | 2015-08-15 | AML17 TRIAL | 01 | N | 220024657 | AML17 TRIAL |
| 220016497 | 220006480 | null | 79.8 | Curative (C) | 2013-08-14 | 2013-09-14 | AML17 TRIAL | Y | N | 220024664 | AML17 TRIAL |
| 220016499 | 220006485 | 1.92 | 114 | Curative (C) | 2013-06-08 | 2013-10-13 | FLAG + Idarubicin | N | N | 220024673 | FLAG + IDARUBICIN |
| 220016500 | 220006487 | 1.55 | 131 | Curative (C) | 2015-10-08 | 2015-10-08 | FLAG + Idarubicin | 1 | N | 220024674 | FLAG + IDARUBICIN |
| 220016501 | 220006490 | 1.81 | 94 | Adjuvant (A) | 2014-07-21 | 2014-07-20 | FLAG + Idarubicin | 02 | N | 220024676 | FLAG + IDARUBICIN |
| 220016503 | 220006495 | 1.63 | 78 | Adjuvant (A) | 2018-04-22 | 2018-08-01 | AML17 TRIAL | N | N | 220024687 | AML17 TRIAL |
| 220016504 | 220006496 | 1.78 | 54.4 | Adjuvant (A) | 2014-04-20 | 2014-04-21 | AML17 TRIAL | N | N | 220024687 | AML17 TRIAL |
| 220016505 | 220013542 | 1.79 | 57.6 | Disease modification (D) | null | 2018-06-01 | AML17 TRIAL | N | N | 220024693 | AML17 TRIAL |
| 220016506 | 220021451 | 1.71 | 89.4 | Palliative (P) | 2018-08-01 | 2018-11-26 | AML17 TRIAL | N | N | 220024701 | AML17 TRIAL |
| 220016508 | 220006504 | null | 102 | Curative (C) | 2014-05-06 | 2014-05-13 | AML17 TRIAL | N | N | 220024761 | AML17 TRIAL |
| 220016509 | 220006506 | 1.65 | 56.9 | Curative (C) | 2016-01-25 | 2016-04-01 | FLAG + Idarubicin | 1 | N | 220024764 | FLAG + IDARUBICIN |
| 220016510 | 220006508 | 1.67 | 68 | Curative (C) | 2014-02-17 | 2014-02-17 | FLAG + Idarubicin | 02 | null | 220024778 | FLAG + IDARUBICIN |